FindTrial
Sign In

Relationship between obstructive sleep apnea hypopnea syndrome and nonalcoholic fatty liver disease and effect of continuous positive airway pressure on serum liver enzyme levels among obstructive sleep apnea hypopnea syndrome

Relationship between obstructive sleep apnea hypopnea syndrome and nonalcoholic fatty liver disease and effect of continuous positive airway pressure on serum liver enzyme levels among obstructive sleep apnea hypopnea syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOB-15007253
Enrollment
Unknown
Registered
2015-08-08
Start date
2015-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive sleep apnea hypopnea syndrome

Interventions

Before CPAP:CPAP

Sponsors

Zhangzhou Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients who suffering snore with or without daytime sleepiness was suspicious of OSAHS.

Exclusion criteria

Exclusion criteria: 1. Patients with excess alcohol intake (defined as >140 g/week for males and 70 g/week for females); 2. Patients with hepatitis virus infection or other causes of chronic liver disease; 3. patients with autoimmune diseases; 4. Patients who were diagnosed OSAS previously treated with operation or are treating with CPAP/oral applicances.

Design outcomes

Primary

MeasureTime frame
liver enzymes;—

Countries

China

Contacts

Public ContactLi-Da Chen
361328175@qq.com+86 0596-2081176

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 20, 2026